Companies / Seres Therapeutics, Inc.
Seres Therapeutics, Inc.
Nasdaq: MCRBCIK 1609809CAMBRIDGE, MA
Financials · FY2025
Ownership
9.9M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 0.36% | 35,600 |
| Institutions | 24.64% | 2,449,589 |
| Public float | 75.00% | 7,456,072 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 7
View all →| Insider | % of shares | Shares |
|---|---|---|
Shaff Eric D.Director | 0.12% | 11,577 |
Young Teresa L.See Remarks | 0.09% | 8,557 |
DesRosier ThomasSee Remarks | 0.08% | 7,789 |
Henn Matthew RSee Remarks | 0.08% | 7,677 |
Brady KellyFormerSee Remarks | — | — |
Kender Richard NSee Remarks · Director | — | — |
Thorell MarellaSee Remarks | — | — |
Institutional holders 36
View all →| Holder | Value | % of shares |
|---|---|---|
| $10.25M | 11.63% | |
| $4.82M | 3.26% | |
| $2.68M | 1.81% | |
| $1.54M | 1.04% | |
| $1.24M | 1.40% | |
| $875.8K | 1.12% | |
| $778.4K | 0.53% | |
| $664.1K | 0.75% | |
| $469.8K | 0.32% | |
| $467.5K | 0.32% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 15, 2026 | Shaff Eric D. Director | Sell | Common Stock | $2.2K | -259 -2.19% | 11,577 0.12% of shares | low |
| Feb 15, 2026 | Henn Matthew R Executive | Sell | Common Stock | $754 | -89 -1.15% | 7,677 0.08% of shares | low |
| Feb 15, 2026 | DesRosier Thomas Executive | Sell | Common Stock | $661 | -78 -0.99% | 7,789 0.08% of shares | low |
| Feb 15, 2026 | Young Teresa L. Executive | Sell | Common Stock | $635 | -75 -0.87% | 8,557 0.09% of shares | low |
| Mar 4, 2026 | Thorell Marella Executive | Grant | Stock Option (right to buy) | — | +23K | 22,500 0.23% of shares | low |
| Feb 15, 2026 | Young Teresa L. Executive | Exercise | Restricted Stock Units | — | -98 -11.16% | 780 <0.01% of shares | low |
| Feb 15, 2026 | Young Teresa L. Executive | Exercise | Restricted Stock Units | — | -133 -20.03% | 531 <0.01% of shares | low |
| Feb 15, 2026 | Young Teresa L. Executive | Exercise | Common Stock | — | +231 +2.75% | 8,632 0.09% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| MCRB | Common Stock | 81750R201 |